Oncology Provider 4baseCare Secures $6 Mn in Series A Funding

With plans to scale up operations, 4baseCare aims to expand its presence not only across India but also in other countries in Asia and the Middle East.

Bengaluru-based 4baseCare, a precision oncology solutions provider, has successfully raised $6 million in Series A funding, led by Yali Capital along with other investors.

The startup, which leverages advanced genomics and digital health technology, aims to revolutionize cancer care through personalized treatment solutions.

"Our journey from developing TARGT Indiegene to positively affecting the lives of over 10,000 patients has been incredibly rewarding," said Hitesh Goswami, CEO and cofounder of 4baseCare.

The new funding will enable the startup to enhance its product offerings and further its mission of making personalized cancer care accessible to millions.

Expansion Plans

With plans to scale up operations, 4baseCare aims to expand its presence in India along with other countries in Asia and the Middle East.

The startup has also announced its goal to establish genomics laboratories in the Philippines, Nepal, and Dubai in the coming months.

These labs will focus on building advanced genomics and digital health solutions, including advanced data analytics, improved clinical insights, and data-driven treatment recommendations.

4baseCare’s innovative approach has garnered attention from industry leaders, including Mathew Cyriac, Founding General Partner of Yali Capital, who highlighted the significant opportunities in the genomics landscape for cancer care.

He said, "The genomics landscape in cancer care offers a tremendous opportunity to create impactful businesses while improving millions of lives. As a deep tech-focused fund, we are particularly excited about 4baseCare’s ability to enhance genomic tests with data from underrepresented populations, leading to improved treatment recommendations.”

The startup’s advisory board includes experts in genomics and technology, and it recently welcomed Francis deSouza, a Silicon Valley veteran and former CEO of Illumina, as a key addition.

The startup reports that since its inception, 4baseCare’s genomic tests have impacted over 10,000 cancer patients across Southeast Asia, and the startup seeks to continue to push the boundaries of personalized oncology care.

Recent Healthcare Fundings

In related news, Udaipur-based digital healthcare startup Karma Primary Healthcare recently secured INR 11 Cr (approximately USD 1.3 million) in Series A funding from the UBS Optimus Foundation. The round also saw contributions from 1Crowd and other investors.

Karma Primary Healthcare planned to use the funds to advance its technology, extend value-added services, and enhance its team. It sought to focus on developing a patient-centric care model for rural areas in India.

Additionally, Delhi-based Visit Health raised INR 250 Cr+ ($29.8 million) through a combination of private placements, debt financing investments, and the acquisition of stakes held by PB Fintech’s subsidiary, Docprime Technologies.